<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Friends of Heroes - National Light The Night Team &#187; T-cell Lymphoma</title>
	<atom:link href="http://www.friendsofheroes.org/tag/t-cell-lymphoma/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.friendsofheroes.org</link>
	<description></description>
	<lastBuildDate>Wed, 17 Aug 2011 06:21:54 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=</generator>
		<item>
		<title>Research Q &amp; A</title>
		<link>http://www.friendsofheroes.org/2008/07/research-q-a/</link>
		<comments>http://www.friendsofheroes.org/2008/07/research-q-a/#comments</comments>
		<pubDate>Thu, 31 Jul 2008 04:28:13 +0000</pubDate>
		<dc:creator>Christy</dc:creator>
				<category><![CDATA[Cancer Research Notes]]></category>
		<category><![CDATA[Leukemia & Lymphoma Society]]></category>
		<category><![CDATA[Patient Services]]></category>
		<category><![CDATA[Craig Okada]]></category>
		<category><![CDATA[LLS research]]></category>
		<category><![CDATA[Oregon Health and Science University]]></category>
		<category><![CDATA[T-cell Lymphoma]]></category>

		<guid isPermaLink="false">http://www.friendsofheroes.org/?p=180</guid>
		<description><![CDATA[RESEARCHER Q&#38;A   Craig Okada, M.D., Ph.D. Dr. Okada is assistant professor of medicine at Oregon Health &#38; Science University. He is a recipient of an LLS Translational Research Program grant for his cutting-edge lymphoma research.Dr. Okada, what are you and your team working on? We are developing an immunotherapeutic approach to the treatment of T-cell [...]]]></description>
			<content:encoded><![CDATA[<p class="dropcap-first">
<table class="MsoNormalTable" style="width: 490.5pt; mso-cellspacing: 0in; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 0in 0in 0in;" border="0" cellspacing="0" cellpadding="0" width="654">
<tbody>
<tr style="height: 39pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;">
<td style="height: 39pt; background-color: transparent; border: #f0f0f0; padding: 0in;">
<p class="MsoNormal" style="margin: 0in 0in 0pt;"><strong><span style="color: #cc0000; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"><span style="font-size: small;">RESEARCHER Q&amp;A</span></span></strong></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="margin: 0in 0in 0pt;"><span style="display: none; mso-hide: all;"><span style="font-size: small; font-family: Times New Roman;"> </span></span></p>
<table class="MsoNormalTable" style="width: 448px; height: 608px; mso-cellspacing: 0in; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 0in 0in 0in;" border="0" cellspacing="0" cellpadding="0" width="448">
<tbody>
<tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;">
<td style="background-color: transparent; border: #f0f0f0; padding: 0in;" valign="top">
<p class="MsoNormal" style="margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;">Craig Okada, M.D., Ph.D.</span></strong></p>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"><a href="http://www.friendsofheroes.org/wp-content/uploads/2008/07/dr-okada.jpg" rel="shadowbox[post-180];player=img;"><img class="alignleft size-medium wp-image-179" title="dr-okada" src="http://www.friendsofheroes.org/wp-content/uploads/2008/07/dr-okada.jpg" alt="" width="144" height="166" /></a><br />
</span></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"></div>
<div class="MsoNormal" style="margin: 0in 0in 0pt;"><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;">Dr. Okada is assistant professor of medicine at Oregon Health &amp; Science University. He is a recipient of an LLS <em>Translational Research Program</em> grant for his cutting-edge lymphoma research.<strong>Dr. Okada, what are you and your team working on?</strong><br />
We are developing an immunotherapeutic approach to the treatment of T-cell malignancies. We are using monoclonal antibodies that bind to a unique molecule found on the surface of different lymphoma cells (TCR idiotype) and combining antibodies with tumor TCR vaccine.</span></div>
<p><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"><strong>What&#8217;s novel or innovative about this approach?</strong><br />
Using monoclonal antibodies and TCR idiotype vaccine may be able to more specifically attack tumor cells without injuring normal immune cells. The vaccine will hopefully stimulate long lived anti-tumor activity, reducing the risk of recurrent disease.<strong>How will it one day help patients?</strong><br />
Patients with T-cell lymphoma tend to have a less favorable outcome than patients with B-cell lymphoma, the most common form of the disease. We hope that developing T-cell lymphoma specific treatments will improve the treatment for these patients.</p>
<p><strong>Are you close to clinical trials?</strong><br />
We are still several years from clinical trials.</p>
<p><strong>What other projects are you excited about and believe will benefit patients?</strong><br />
There are several new drugs that have anti-tumor activity in T-cell malignancies. We are actively determining in clinical trials how well they work and if they can be used in combination with older drugs without adding significant toxicities.</p>
<div><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"><strong>What are some of your hobbies and non-research interests?</strong><br />
When I am not working in the laboratory or seeing patients, I enjoy hiking, rock climbing and spending time with my family.</span></div>
<p><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"> <span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"> </p>
<p></span></span></span></p>
<p><span style="font-size: 10pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;"> </p>
<p></span></span></p>
<p> </p>
<p class="MsoNormal" style="margin: 0in 0in 0pt;"><span style="font-size: x-small;">Article Courtsey of LLS Please visit <a href="http://www.lls.org">www.lls.org</a> for more information.</span></p>
</td>
</tr>
</tbody>
</table>


<div class="shr-bookmarks shr-bookmarks-expand shr-bookmarks-center shr-bookmarks-bg-caring-old">
<ul class="socials">
		<li class="shr-facebook">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=5&amp;tags=&amp;ctype=" rel="nofollow" title="Share this on Facebook">Share this on Facebook</a>
		</li>
		<li class="shr-delicious">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=2&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Share this on del.icio.us">Share this on del.icio.us</a>
		</li>
		<li class="shr-twitter">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=%24%7Btitle%7D+-+%24%7Bshort_link%7D&amp;service=7&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Tweet This!">Tweet This!</a>
		</li>
		<li class="shr-digg">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=3&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Digg this!">Digg this!</a>
		</li>
		<li class="shr-googlereader">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=207&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Add this to Google Reader">Add this to Google Reader</a>
		</li>
		<li class="shr-linkedin">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=88&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Share this on LinkedIn">Share this on LinkedIn</a>
		</li>
		<li class="shr-stumbleupon">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=38&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Stumble upon something good? Share it on StumbleUpon">Stumble upon something good? Share it on StumbleUpon</a>
		</li>
		<li class="shr-googlebuzz">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=257&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Post on Google Buzz">Post on Google Buzz</a>
		</li>
		<li class="shr-reddit">
			<a href="http://www.shareaholic.com/api/share/?title=Research+Q+%26+A&amp;link=http://www.friendsofheroes.org/2008/07/research-q-a/&amp;notes=%0D%0A%0D%0A%0D%0A%0D%0ARESEARCHER%20Q%26amp%3BA%0D%0A%0D%0A%0D%0A%0D%0A%C2%A0%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ACraig%20Okada%2C%20M.D.%2C%20Ph.D.%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0A%0D%0ADr.%C2%A0Okada%20is%20assistant%20professor%20of%20medicine%20at%20Oregon%20Health%20%26amp%3B%20Science%20University.%20He%20is%20a%20recipient%20of%20an%20LLS%20Translational%20Research%20Program%20grant%20for%20his%20cutting-edge%20lymphoma%20research.Dr.%20Okada&amp;short_link=&amp;shortener=bitly&amp;shortener_key=&amp;v=1&amp;apitype=1&amp;apikey=8afa39428933be41f8afdb8ea21a495c&amp;source=Shareaholic&amp;template=&amp;service=40&amp;tags=&amp;ctype=" rel="nofollow" class="external" title="Share this on Reddit">Share this on Reddit</a>
		</li>
</ul><div style="clear: both;"></div><div class="shr-getshr" style="visibility:hidden;font-size:10px !important"><a target="_blank" href="http://www.shareaholic.com/?src=pub">Get Shareaholic</a></div><div style="clear: both;"></div></div>

]]></content:encoded>
			<wfw:commentRss>http://www.friendsofheroes.org/2008/07/research-q-a/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

